✦ LIBER ✦

Therapeutic effects of rhTNF alone and in combination with kengshengmycin in experimental human ovarian cancer

✍ Scribed by Zhao Enfeng; Zhou Meiqing; Fu Caiying; Shen Beifen; Zhang Quan; Lian Lijuan

Book ID: 112823721
Publisher: Chinese Anti-Cancer Association
Year: 1996
Tongue: English
Weight: 241 KB
Volume: 8
Category: Article
ISSN: 1000-9604
DOI: 10.1007/bf02674963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experimental Osteomyelitis. IV. Therapeu

Experimental Osteomyelitis. IV. Therapeutic Trials with Rifampin Alone and in Combination with Gentamicin, Sisomicin, and Cephalothin

✍ Norden, C. W. 📂 Article 📅 1975 🏛 University of Chicago Press 🌐 English ⚖ 543 KB

The effects of estrogen, progesterone, a

The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro

✍ Kim R. Geisinger; Michael E. Berens; Yvonne Duckett; Charles E. Welander; Timoth 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 669 KB

The effects of estradiol (E), medroxyprogesterone acetate (MPA), and tamoxifen (TAM) on the growth of a human ovarian carcinoma cell line, BG-1, were evaluated using a tumor clonogenic assay (HTCA). BG-1 contains significant quantities of estrogen and progesterone receptors. Growth inhibition by TAM

Effects of pexiganan alone and combined

Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock

✍ Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Wojciech K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 360 KB

807 Experimental Therapeutic Approach of

807 Experimental Therapeutic Approach of Orthotopic and Subcutaneous Human Retinoblastoma Xenografts by the Human Anti-VEGF Antibody Bevacizumab, Alone or in Combination With Carboplatin

✍ D. Decaudin; F. Assayag; N. Cassoux; O. Chouchane-Mlik; F Némati; A. Thuleau; I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

515 Therapeutic advantage of chemotherap

515 Therapeutic advantage of chemotherapy drugs in combination with PARP inhibitor PF-01367338 (AG-014699) in human ovarian cancer cells

✍ M. Ihnen; K. Manivong; M. Chalukya; J. Dering; T. Kolarova; G. Los; J. Christens 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Augmentative Effects of Intracellular Ch

Augmentative Effects of Intracellular Chemotherapy Penetration Combined with Hyperthermia in Human Ovarian Cancer Cells Lines

✍ Ron Maymon; Batia Bar-Shira Maymon; Michael Holzinger; Boris Tartakovsky; Judith 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 303 KB